English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51649137    線上人數 :  811
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"tang j l"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 796-805 / 936 (共94頁)
<< < 75 76 77 78 79 80 81 82 83 84 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2014 The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression Lee F.-Y.; Tseng M.-H.; Huang C.-F.; Chen P.-H.; Li L.-Y.; Chen Y.-K.; Hou H.-A.; Kuo Y.-Y.; HWEI-FANG TIEN; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; Tang J.-L.; Yao M.
臺大學術典藏 2014 SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution Tseng M.-H.; Chen C.-Y.; Liu C.-Y.; Kuo Y.-Y.; Wu S.-J.; Chou W.-C.; Hou H.-A.; Lin C.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN
臺大學術典藏 2014 Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia Lee M.-C.; Liu M.-C.; Kuo Y.-Y.; Lee F.-Y.; Huang C.-F.; Chiang Y.-C.; Tseng M.-H.; Lai Y.-J.; Tang J.-L.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Lin C.-C.; Hou H.-A.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN
臺大學術典藏 2014 Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma MING YAO; Lin C.-W.; Lin H.-H.; Huang S.-Y.; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Chen Y.-C.; Lu H.-Y.; Wu S.-J.; Tang J.-L.; Tien H.-F.
臺大學術典藏 2014 The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression Tseng M.-H.; Li L.-Y.; Chen P.-H.; Chen Y.-K.; Hou H.-A.; Kuo Y.-Y.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; Tang J.-L.; MING YAO; Tien H.-F.
臺大學術典藏 2014 Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma SHANG-YI HUANG; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F.
臺大學術典藏 2014 Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Huang S.-Y.; Ko B.-S.; Yao M.; Chen C.-Y.; Hu F.-C.; Hou H.-A.; Chou W.-C.; Tang J.-L.; Chou S.-C.
臺大學術典藏 2014 IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients Huang S.-Y.; Kuo Y.-Y.; Li C.-C.; Tang J.-L.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chou W.-C.; Yang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Lin C.-T.; Hsu S.-C.; Ko B.-S.; Chen C.-Y.
臺大學術典藏 2014 Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma Yao M.; Lin H.-H.; Lin C.-W.; Huang S.-Y.; Tien H.-F.; Tang J.-L.; SHANG-JU WU; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.
臺大學術典藏 2014 Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations Hou H.-A.; Tang J.-L.; Chou S.-C.; Tien H.-F.; Chen Y.-C.; Tsay W.; Huang S.-Y.; Ko B.-S.; MING YAO; Chen C.-Y.; Chou W.-C.; Hu F.-C.

顯示項目 796-805 / 936 (共94頁)
<< < 75 76 77 78 79 80 81 82 83 84 > >>
每頁顯示[10|25|50]項目